1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine,
TAK 438,
TAK-438,
TAK438,
Vonoprazan,
Vonoprazan,
881681-00-1,
TAK-438 free base,
UNII-1R5L3J156G,
1R5L3J156G,
1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine,
1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine,
1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonyl-pyrrol-3-yl]-~{N}-methyl-methanamine,
Vonoprazan [INN],
1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1h-pyrrol-3-yl]-n-methylmethanamine,
TAK-438 (free base),
SCHEMBL194487,
CHEMBL2079130,
DTXSID20236869,
CHEBI:136048,
BCP13240,
KS-00000TU1,
ZINC34842823,
AKOS030632802,
CS-5555,
DB11739,
QC-7250,
SB16719,
1-(5-(2-Fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine,
1H-pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-,
NCGC00386236-05,
AK548051,
DS-19419,
HY-100007,
4-(Methylaminomethyl)-2-(2-fluorophenyl)-1H-pyrrole-1-yl(3-pyridyl) sulfone,
HKT,
takecab,
Vonoprazan Fumarate,
TAK-438,
881681-00-1 (free base),
5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde,
1260141-27-2,
881677-11-8,